UMGCCC Clinical Trials

  • More About Clinical Trials
  • Deciding to Enroll
  • Questions to Ask
  • For More Information
  • Research
  • Cancer Overviews
  • Treatment Programs
  • Physicians and Staff
Protocol SummaryBack To Search Instructions
Protocol No.SWOG1400IPrincipal InvestigatorScilla, Katherine
PhasePhase III
Age GroupAdult
TitleS1400I A Phase III Randomized Study of Nivolumab Plus Ipilimumab Versus Nivolumab for Previously Treated Patients with Stage IV Squamous Cell Lung Cancer and No Matching Biomarker (Lung-MAP Sub-Study)
Applicable Disease SitesLung
Drugs InvolvedIpilimumab (MDX-010
BMS-734016)
Nivolumab
StatusOpen
Treatment TypeTreatment
ClinicalTrials.gov http://www.clinicaltrials.gov/ct2/show/NCT02785952
ContactGreenebaum Cancer Center Maha Khalil, PhD Phone:410-328-5009
Pager:
Email:mkhalil@umm.edu
Back to Protocol Listing